| Entry |
|
|---|
| Name |
L-Valine;
2-Amino-3-methylbutyric acid
|
|---|
| Formula |
C5H11NO2
|
|---|
| Exact mass |
117.079
|
|---|
| Mol weight |
117.1463
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Reaction |
|
|---|
| Pathway |
| map00280 | Valine, leucine and isoleucine degradation |
| map00290 | Valine, leucine and isoleucine biosynthesis |
| map00311 | Penicillin and cephalosporin biosynthesis |
| map00770 | Pantothenate and CoA biosynthesis |
| map01060 | Biosynthesis of plant secondary metabolites |
| map01063 | Biosynthesis of alkaloids derived from shikimate pathway |
| map01110 | Biosynthesis of secondary metabolites |
| map01210 | 2-Oxocarboxylic acid metabolism |
| map04974 | Protein digestion and absorption |
| map05230 | Central carbon metabolism in cancer |
|
|---|
| Module |
| M00019 | Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine |
| M00119 | Pantothenate biosynthesis, valine/L-aspartate => pantothenate |
| M00672 | Penicillin biosynthesis, aminoadipate + cycteine + valine => penicillin |
| M00673 | Cephamycin C biosynthesis, aminoadipate + cycteine + valine => cephamycin C |
|
|---|
| Network |
nt06024 Valine, leucine and isoleucine degradation |
|---|
| Enzyme |
|
|---|
| Brite |
Compounds with biological roles [BR:br08001]
Peptides
Amino acids
Common amino acids
C00183 Valine (Val)
Risk category of Japanese OTC drugs [BR:br08312]
Third-class OTC drugs
Inorganic and organic chemicals
L-Valine
D00039 Valine (USP)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00039 L-Valine
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 8
1 C1c C 24.8500 -19.0764
2 C1c C 26.0666 -18.3804
3 C6a C 23.6334 -18.3629
4 N1a N 24.8442 -20.4802
5 C1a C 27.2716 -19.0881
6 C1a C 26.0725 -16.9825
7 O6a O 22.4226 -19.0589
8 O6a O 23.6392 -16.9707
BOND 7
1 1 2 1
2 1 3 1
3 1 4 1 #Down
4 2 5 1
5 2 6 1
6 3 7 1
7 3 8 2
|
|---|
